FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

1187387000: Levosalbutamol sulfate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2022. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
4673592011 Levosalbutamol sulfate (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
4673593018 Levosalbutamol sulfate en Synonym Active Entire term case insensitive SNOMED CT core module
4673594012 Levalbuterol sulfate en Synonym Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Levosalbutamol sulfate Is a Substance with beta adrenergic receptor agonist mechanism of action true Inferred relationship Existential restriction modifier
Levosalbutamol sulfate Is a Ethanolamine and/or ethanolamine derivative true Inferred relationship Existential restriction modifier
Levosalbutamol sulfate Has disposition Beta-2 adrenergic receptor agonist true Inferred relationship Existential restriction modifier
Levosalbutamol sulfate Is modification of Levosalbutamol true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation conventional release pressurized solution for inhalation (clinical drug) Has precise active ingredient True Levosalbutamol sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely ipratropium bromide 40 microgram and levosalbutamol (as levosalbutamol sulfate) 100 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has precise active ingredient True Levosalbutamol sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely beclometasone dipropionate 100 microgram and levosalbutamol (as levosalbutamol sulfate) 100 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has precise active ingredient True Levosalbutamol sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely beclometasone dipropionate 50 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation pressurized conventional release solution for inhalation (clinical drug) Has precise active ingredient True Levosalbutamol sulfate Inferred relationship Existential restriction modifier 1
Product containing precisely levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation conventional release pressurized solution for inhalation (clinical drug) Has precise active ingredient True Levosalbutamol sulfate Inferred relationship Existential restriction modifier 1

This concept is not in any reference sets

Back to Start